查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1298659

肝病治療市場：2023-2028年全球行業趨勢、佔有率、規模、成長、機會和預測

Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2022年，全球肝病治療市場規模達到223億美元。展望未來，IMARC Group預計，到2028年，市場規模將達到330億美元，在2023-2028年期間呈現6.43%的成長率（CAGR）。

肝臟是人體的一個重要器官，發揮著重要的功能，如儲存維生素和營養物質，清除血液中的有害物質，並保持體內化學物質的充分平衡。癌症、肝炎、自身免疫性疾病和遺傳性疾病是一些常見的肝病。這些疾病通常由感染、遺傳、肥胖、糖尿病和免疫系統異常引起。一些廣泛使用的肝病治療技術包括疫苗、化療、抗病毒藥物、免疫球蛋白、皮質類固醇和免疫抑製劑。肝病治療有助於膽固醇和荷爾蒙的排泄，增加膽汁分泌和酶的激活。

肝病治療的市場趨勢：

全球範圍內的老年人口不斷增加，容易出現各種慢性疾病，包括肝病，這是推動市場成長的主要因素之一。飲食模式的改變和久坐的生活方式正在推動市場的成長。此外，由於高膽固醇、肥胖、高血壓和糖尿病導致的脂肪肝發病率的增加，也有利於市場的成長。此外，各種技術進步，如生物人工肝的開發，正在為市場成長提供動力。它利用再生的肝臟細胞來替代肝臟功能，廣泛用於急性肝衰竭患者。與此相應，抗病毒藥物的迅速採用，因為它們安全有效，協助抑制乙型肝炎病毒，並有助於降低患肝硬化和肝細胞癌的風險，正在對市場成長產生積極的影響。除此之外，研究和開發（R&D）活動的增加，醫療保健行業的顯著成長，以及政府為促進公眾健康而採取的各種計劃，都為市場創造了積極的前景。

目錄

第一章：前言

第二章：範圍和方法

  • 研究的目標
  • 利益相關者
  • 數據來源
    • 主要來源
    • 二級來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第三章：執行摘要

第四章：簡介

  • 概述
  • 主要行業趨勢

第五章：全球肝病治療市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第六章：按治療類型分類的市場

  • 抗病毒藥物
    • 市場趨勢
    • 市場預測
  • 免疫抑製劑
    • 市場趨勢
    • 市場預測
  • 疫苗
    • 市場趨勢
    • 市場預測
  • 免疫球蛋白
    • 市場趨勢
    • 市場預測
  • 皮質類固醇
    • 市場趨勢
    • 市場預測
  • 靶向治療
    • 市場趨勢
    • 市場預測
  • 化療
    • 市場趨勢
    • 市場預測

第7章：按疾病類型分類的市場

  • 肝炎
    • 市場趨勢
    • 市場預測
  • 自身免疫性疾病
    • 市場趨勢
    • 市場預測
  • 非酒精性脂肪肝(NAFLD)
    • 市場趨勢
    • 市場預測
  • 癌症
    • 市場趨勢
    • 市場預測
  • 遺傳性疾病
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第8章：按終端用戶分類的市場

  • 醫院
    • 市場趨勢
    • 市場預測
  • 非住院手術中心
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第九章：按地區分類的市場

  • 北美洲
    • 美國
      • 市場趨勢
      • 市場預測
    • 加拿大
      • 市場趨勢
      • 市場預測
  • 亞太地區
    • 中國
      • 市場趨勢
      • 市場預測
    • 日本
      • 市場趨勢
      • 市場預測
    • 印度
      • 市場趨勢
      • 市場預測
    • 韓國
      • 市場趨勢
      • 市場預測
    • 澳大利亞
      • 市場趨勢
      • 市場預測
    • 印尼
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 歐洲
    • 德國
      • 市場趨勢
      • 市場預測
    • 法國
      • 市場趨勢
      • 市場預測
    • 英國
      • 市場趨勢
      • 市場預測
    • 義大利
      • 市場趨勢
      • 市場預測
    • 西班牙
      • 市場趨勢
      • 市場預測
    • 俄羅斯
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢
      • 市場預測
    • 墨西哥
      • 市場趨勢
      • 市場預測
    • 其他國家
      • 市場趨勢
      • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 按國家分類的市場
    • 市場預測

第十章：SWOT分析

  • 概述
  • 優勢
  • 劣勢
  • 機會
  • 威脅

第十一章：價值鏈分析

第十二章：波特五力分析

  • 概述
  • 買方的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第十三章：價格分析

第十四章：競爭格局

  • 市場結構
  • 主要參與者
  • 主要參與者的概況
    • Abbott Laboratories
    • AbbVie Inc.
    • Astellas Pharma Inc.
    • Bristol-Myers Squibb Company
    • Eli Lilly and Company
    • Emergent BioSolutions Inc.
    • F. Hoffmann-La Roche AG
    • Gilead Sciences Inc.
    • GlaxoSmithKline plc
    • Merck & Co. Inc.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi SA
    • Takeda Pharmaceutical Company Limited
    • Viatris Inc.
Product Code: SR112023A5023

The global liver disease treatment market size reached US$ 22.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 33.0 Billion by 2028, exhibiting a growth rate (CAGR) of 6.43% during 2023-2028.

The liver is a vital organ of the human body that performs significant functions, such as storing vitamins and nutrients, removing harmful substances from the blood, and maintaining an adequate balance of chemicals in the body. Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases. These diseases are commonly caused by infections, genetics, obesity, diabetes, and immune system abnormalities. Some of the widely used therapeutic techniques for liver diseases include vaccines, chemotherapy, antiviral drugs, immunoglobulins, corticosteroids, and immunosuppressants. Liver disease treatment aids in the excretion of cholesterol and hormones, increases bile production and enzyme activation.

Liver Disease Treatment Market Trends:

The rising geriatric population, which is suspetible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting the market growth. Additionally, the increasing prevalence of fatty liver disease due to high cholesterol, obesity, hypertension (high blood pressure), and diabetes is favoring the market growth. Moreover, various technological advancements, such as the development of the bioartificial liver, are providing an impetus to the market growth. It utilizes regenerated liver cells to replace liver functions and is widely used for acute liver failure patients. In line with this, the rapid adoption of antiviral drugs as they are safe and effective, assist in suppressing the hepatitis B virus, and help in reducing the risk of developing cirrhosis and hepatocellular carcinoma, is positively impacting the market growth. Apart from this, increasing research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote public health are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liver disease treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on treatment type, disease type and end user.

Breakup by Treatment Type:

Antiviral Drugs

Immunosuppressants

Vaccines

Immunoglobulins

Corticosteroids

Targeted Therapy

Chemotherapy

Breakup by Disease Type:

Hepatitis

Autoimmune Diseases

Non-alcoholic Fatty Liver Disease (NAFLD)

Cancer

Genetic Disorders

Others

Breakup by End User:

Hospitals

Ambulatory Surgical Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

Key Questions Answered in This Report

1. What was the size of the global liver disease treatment market in 2022?

2. What is the expected growth rate of the global liver disease treatment market during 2023-2028?

3. What are the key factors driving the global liver disease treatment market?

4. What has been the impact of COVID-19 on the global liver disease treatment market?

5. What is the breakup of the global liver disease treatment market based on the treatment type?

6. What is the breakup of the global liver disease treatment market based on the disease type?

7. What is the breakup of the global liver disease treatment market based on the end user?

8. What are the key regions in the global liver disease treatment market?

9. Who are the key players/companies in the global liver disease treatment market?

Table of Contents

1   Preface

2   Scope and Methodology

  • 2.1  Objectives of the Study
  • 2.2  Stakeholders
  • 2.3  Data Sources
    • 2.3.1  Primary Sources
    • 2.3.2  Secondary Sources
  • 2.4  Market Estimation
    • 2.4.1  Bottom-Up Approach
    • 2.4.2  Top-Down Approach
  • 2.5  Forecasting Methodology

3   Executive Summary

4   Introduction

  • 4.1  Overview
  • 4.2  Key Industry Trends

5   Global Liver Disease Treatment Market

  • 5.1  Market Overview
  • 5.2  Market Performance
  • 5.3  Impact of COVID-19
  • 5.4  Market Forecast

6   Market Breakup by Treatment Type

  • 6.1  Antiviral Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2  Immunosuppressants
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3  Vaccines
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4  Immunoglobulins
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5  Corticosteroids
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6  Targeted Therapy
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7  Chemotherapy
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7   Market Breakup by Disease Type

  • 7.1  Hepatitis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2  Autoimmune Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3  Non-alcoholic Fatty Liver Disease (NAFLD)
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4  Cancer
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5  Genetic Disorders
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6  Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8   Market Breakup by End User

  • 8.1  Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2  Ambulatory Surgical Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3  Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9   Market Breakup by Region

  • 9.1  North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2  Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3  Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4  Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5  Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10  SWOT Analysis

  • 10.1  Overview
  • 10.2  Strengths
  • 10.3  Weaknesses
  • 10.4  Opportunities
  • 10.5  Threats

11  Value Chain Analysis

12  Porters Five Forces Analysis

  • 12.1  Overview
  • 12.2  Bargaining Power of Buyers
  • 12.3  Bargaining Power of Suppliers
  • 12.4  Degree of Competition
  • 12.5  Threat of New Entrants
  • 12.6  Threat of Substitutes

13  Price Analysis

14  Competitive Landscape

  • 14.1  Market Structure
  • 14.2  Key Players
  • 14.3  Profiles of Key Players
    • 14.3.1  Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2  AbbVie Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3  Astellas Pharma Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4  Bristol-Myers Squibb Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5  Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6  Emergent BioSolutions Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7  F. Hoffmann-La Roche AG
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8  Gilead Sciences Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9  GlaxoSmithKline plc
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10  Merck & Co. Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11  Novartis AG
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12  Pfizer Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13  Sanofi S.A.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis
    • 14.3.14  Takeda Pharmaceutical Company Limited
      • 14.3.14.1 Company Overview
      • 14.3.14.2 Product Portfolio
      • 14.3.14.3 Financials
      • 14.3.14.4 SWOT Analysis
    • 14.3.15  Viatris Inc.
      • 14.3.15.1 Company Overview
      • 14.3.15.2 Product Portfolio
      • 14.3.15.3 Financials

List of Figures

  • Figure 1: Global: Liver Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Liver Disease Treatment Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Liver Disease Treatment Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Liver Disease Treatment Market: Breakup by Treatment Type (in %), 2022
  • Figure 5: Global: Liver Disease Treatment Market: Breakup by Disease Type (in %), 2022
  • Figure 6: Global: Liver Disease Treatment Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Liver Disease Treatment Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Liver Disease Treatment (Antiviral Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Liver Disease Treatment (Antiviral Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Liver Disease Treatment (Immunosuppressants) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Liver Disease Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Liver Disease Treatment (Vaccines) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Liver Disease Treatment (Vaccines) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Liver Disease Treatment (Immunoglobulins) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Liver Disease Treatment (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Liver Disease Treatment (Corticosteroids) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Liver Disease Treatment (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Liver Disease Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Liver Disease Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Liver Disease Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Liver Disease Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Liver Disease Treatment (Hepatitis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Liver Disease Treatment (Hepatitis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Liver Disease Treatment (Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Liver Disease Treatment (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Liver Disease Treatment (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Liver Disease Treatment (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Liver Disease Treatment (Genetic Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Liver Disease Treatment (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Liver Disease Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Liver Disease Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Liver Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Liver Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Liver Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Liver Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia-Pacific: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia-Pacific: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Liver Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Liver Disease Treatment Market: Breakup by Country (in %), 2022
  • Figure 88: Middle East and Africa: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 89: Global: Liver Disease Treatment Industry: SWOT Analysis
  • Figure 90: Global: Liver Disease Treatment Industry: Value Chain Analysis
  • Figure 91: Global: Liver Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Liver Disease Treatment Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Liver Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2023-2028
  • Table 3: Global: Liver Disease Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
  • Table 4: Global: Liver Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Liver Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Liver Disease Treatment Market: Competitive Structure
  • Table 7: Global: Liver Disease Treatment Market: Key Players